Apoorva Singh Selected Research

proxyl nitroxide

1/2017

Effect of mitochondrially targeted carboxy proxyl nitroxide on Akt-mediated survival in Daudi cells: Significance of a dual mode of action.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Apoorva Singh Research Topics

Disease

2	Neoplasms (Cancer) 01/2020 - 01/2017
1	Bradycardia 01/2022
1	Temporomandibular ankylosis 01/2022
1	Acidosis 01/2022
1	Ankylosis 01/2022
1	Dysbiosis 09/2020
1	Clostridium Infections 09/2020
1	Acne Vulgaris 01/2020
1	Skin Neoplasms (Skin Cancer) 01/2020
1	Postpartum Hemorrhage 01/2019
1	Visceral Leishmaniasis (Kala Azar) 01/2017
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2017
1	Hypoxia (Hypoxemia) 01/2017
1	Gestational Diabetes (Gestational Diabetes Mellitus) 09/2015

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 01/2020 - 01/2017
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2022
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2020
1	Liposomes (Liposome)IBA 01/2020
1	Benzoyl Peroxide FDA LinkGeneric 01/2020
1	Adapalene (Differin)FDA LinkGeneric 01/2020
1	Misoprostol (Cytotec)FDA LinkGeneric 01/2019
1	OxazolesIBA 01/2017
1	proxyl nitroxideIBA 01/2017
1	CarbonIBA 01/2017
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 01/2017
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2017
1	mito-carboxy proxylIBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 09/2015

Therapy/Procedure

1	Replacement Arthroplasty 01/2022
1	Cesarean Section (Caesarean Section) 01/2022
1	Fecal Microbiota Transplantation 09/2020
1	Radiotherapy 01/2020
1	Drug Therapy (Chemotherapy) 01/2020
1	Therapeutics 01/2020